Management of patients with bleeding disorders and educational needs regarding hemophilia a in 23 italian emergency departments - Results from a survey conducted in Piedmont.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
26 10 2022
26 10 2022
Historique:
received:
04
08
2022
accepted:
31
08
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Haemophilia and von Willebrand disease are the bleeding disorders most frequently encountered in the emergency department (ED), that are often the first point of contact for patients. Evidence suggests that management in the ED is currently suboptimal, mainly because the physicians have few opportunities to deal with this kind of patients. We carried out a survey to investigate the management of patients with haemophilia A in Emergency Departments (EDs), and to understand the training needs of the involved physicians. Overall, in Piedmont Region there are 32 EDs, and considering that our survey was conducted on 21 physicians working in 23 Emergency Departments (EDs), this number is representative of the Region's reality. The interviews were conducted through face-to-face meetings, including general aspects regarding the clinical characteristics and the management of patients, and self-evaluation of knowledge and interest in receiving information about the disease. In 2019, 131 patients with haemophilia A were admitted (108 adults, 23 paediatric). The best-known and most widely available and used treatments were plasma derivatives, followed by first- and second-generation recombinant FVIII. More recent recombinant and bypassing agents were less known. Half of the interviewees considered their -knowledge of bleeding disorders in general and haemophilia in particular to be "basic", and only one third defined it as "good"; however, 86% expressed great interest in receiving information about the topic. The survey confirms the needs related to the clinical management of rare inherited clotting disorders in EDs. The physicians involved are keen to overcome this lack of knowledge, and proper initiatives should be implemented.
Sections du résumé
BACKGROUND
Haemophilia and von Willebrand disease are the bleeding disorders most frequently encountered in the emergency department (ED), that are often the first point of contact for patients. Evidence suggests that management in the ED is currently suboptimal, mainly because the physicians have few opportunities to deal with this kind of patients.
OBJECTIVES
We carried out a survey to investigate the management of patients with haemophilia A in Emergency Departments (EDs), and to understand the training needs of the involved physicians.
METHODS
Overall, in Piedmont Region there are 32 EDs, and considering that our survey was conducted on 21 physicians working in 23 Emergency Departments (EDs), this number is representative of the Region's reality. The interviews were conducted through face-to-face meetings, including general aspects regarding the clinical characteristics and the management of patients, and self-evaluation of knowledge and interest in receiving information about the disease.
RESULTS
In 2019, 131 patients with haemophilia A were admitted (108 adults, 23 paediatric). The best-known and most widely available and used treatments were plasma derivatives, followed by first- and second-generation recombinant FVIII. More recent recombinant and bypassing agents were less known. Half of the interviewees considered their -knowledge of bleeding disorders in general and haemophilia in particular to be "basic", and only one third defined it as "good"; however, 86% expressed great interest in receiving information about the topic.
CONCLUSIONS
The survey confirms the needs related to the clinical management of rare inherited clotting disorders in EDs. The physicians involved are keen to overcome this lack of knowledge, and proper initiatives should be implemented.
Identifiants
pubmed: 36300218
doi: 10.23750/abm.v93i5.13538
pmc: PMC9686153
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2022293Références
Transfus Apher Sci. 2019 Oct;58(5):565-568
pubmed: 31427262
Res Pract Thromb Haemost. 2020 Mar 19;4(4):644-651
pubmed: 32548564
Transfus Apher Sci. 2019 Oct;58(5):553-562
pubmed: 31416711
Haemophilia. 2016 Mar;22(2):263-267
pubmed: 26560894
Haemophilia. 2020 May;26(3):422-430
pubmed: 32147924
Curr Opin Hematol. 2005 Sep;12(5):390-4
pubmed: 16093785
J Pediatr. 2002 Oct;141(4):548-52
pubmed: 12378196
Haemophilia. 2017 May;23(3):e188-e193
pubmed: 28233431
Pediatr Emerg Med Pract. 2015 Sep;12(9):1-20; quiz 20-1
pubmed: 26284379
J Emerg Med. 2020 May;58(5):756-766
pubmed: 32249010
Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
Emerg Med J. 2001 Jul;18(4):246-9
pubmed: 11435355
Pediatr Rev. 2013 Jul;34(7):289-94; quiz 295
pubmed: 23818083
Semin Thromb Hemost. 2016 Jul;42(5):589-98
pubmed: 27071049
J Emerg Med. 2010 Aug;39(2):158-65
pubmed: 18757163